Progesterone-Related Issues and Coping Strategies for Women Undergoing Assisted Reproductive Treatment

Basit Öğe Kaydı
dc.authoridGulen Savas, Hacer/0000-0002-3307-6162en_US
dc.authoridsuzer, filiz/0000-0002-2539-8591en_US
dc.contributor.authorKaradeniz, Hilal
dc.contributor.authorDemirci, Nurdan
dc.contributor.authorOzkan, Filiz Suzer
dc.contributor.authorSavas, Hacer Gulen
dc.date.accessioned2024-08-23T16:04:01Z
dc.date.available2024-08-23T16:04:01Z
dc.date.issued2023en_US
dc.departmentDüzce Üniversitesien_US
dc.description.abstractObjective: This study aims to identify the problems experienced by women undergoing assisted reproductive treatment due to progesterone use, as well as their coping strategies.Methods: The study included 145 women who were admitted to an infertility outpatient clinic of a university hospital between July 25 and August 8, 2022. The researchers collected data using a questionnaire designed to assess the problems that might arise due to the use of various types of progesterone-containing drugs and coping methods. The data were evaluated using descriptive statistics in the SPSS program.Results: The mean age of the women was 30.76 & PLUSMN;5.53 years, and the mean duration of their marriages was 6.6 & PLUSMN;4.51 years. Of women 64.8% had primary infertility and 68.3% of women underwent assisted reproductive treatment (ART) at least once before. Women who received intramuscular progesterone treatment during ART frequently experienced pain, swelling, abscess, redness at the injection site. Women who received progesterone treatment vaginally experienced vaginal wetness, drying of the drug in the vagina, lumps, the drug leaving the body, the drug not being completely absorbed, vaginal itching. Women who received progesterone treatment orally experienced sleepiness, nausea, dizziness, headache, fatigue. Women coped with these problems using various methods.Conclusion: The study revealed that women undergoing ART experienced many problems related to the use of progesterone and they attempted to address these issues through their own means. It is necessary to inform patients and to plan nursing interventions to minimize/eliminate these problems.en_US
dc.identifier.doi10.14235/bas.galenos.2023.72691
dc.identifier.endpage307en_US
dc.identifier.issn2148-2373
dc.identifier.issue3en_US
dc.identifier.startpage300en_US
dc.identifier.urihttps://doi.org/10.14235/bas.galenos.2023.72691
dc.identifier.urihttps://hdl.handle.net/20.500.12684/14023
dc.identifier.volume11en_US
dc.identifier.wosWOS:001041614000010en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofBezmialem Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCopingen_US
dc.subjectinfertilityen_US
dc.subjectprogesteroneen_US
dc.subjectassisted reproductive treatmenten_US
dc.subjectLuteal-Phase Supporten_US
dc.subjectDydrogesteroneen_US
dc.subjectCyclesen_US
dc.titleProgesterone-Related Issues and Coping Strategies for Women Undergoing Assisted Reproductive Treatmenten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu